JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
Tweet Send to a FriendGet Alerts ACHN Hot Sheet
Price: $7.74 -0.13%
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade ACHN Now!
JMP Securities upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Market Perform to Market Outperform with a price target of $10.00.
For an analyst ratings summary and ratings history on Achillion Pharmaceuticals click here. For more ratings news on Achillion Pharmaceuticals click here.
Shares of Achillion Pharmaceuticals closed at $5.90 yesterday, with a 52 week range of $3.81-$12.95.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Achillion Pharmaceuticals click here. For more ratings news on Achillion Pharmaceuticals click here.
Shares of Achillion Pharmaceuticals closed at $5.90 yesterday, with a 52 week range of $3.81-$12.95.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Cantor Fitzgerald Upgrades Cubist Pharmaceuticals (CBST) to Hold
- DA Davidson Upgrades Boise Cascade Company (BCC) to Neutral
- Sterne Agee Upgrades Cree (CREE) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
JMP Securities
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
